Health News Headlines
Bristol-Myers, bluebird therapy for multiple myeloma succeeds in mid-stage trial
(Reuters) - Bristol-Myers Squibb Co and bluebird bio Inc said on Friday their experimental therapy for a type of multiple myeloma met the main goal in a mid-stage study.
Socialism has worked in UK and it will work again: Labour's Corbyn
MAIDSTONE, England (Reuters) - The leader of Britain's opposition Labour Party leader Jeremy Corbyn said democratic socialism had improved the living standards of the country's poorest in the past and the party would turn to it again if he wins the Dec. 12 election.
Brushing your teeth could be good for your heart
(Reuters Health) - People who brush their teeth three times a day are less likely to develop atrial fibrillation or heart failure than those with less consistent oral hygiene habits, a Korean study suggests.
Ice bath after workout may not improve fitness
(Reuters Health) - New research throws cold water on a popular exercise recovery regimen, finding that ice baths after a workout may actually impede muscle building.
Grifols says trial shows positive effects in slowing Alzheimer's
BARCELONA (Reuters) - Spain's Grifols said on Friday the latest results from a clinical trial of its Alzheimer's treatment show positive effects by achieving a reduction of the disease's progression in patients with mild and moderate conditions.
Victoria Falls shrink to a trickle, feeding climate change fears
VICTORIA FALLS, Zambia (Reuters) - For decades Victoria Falls, where southern Africa's Zambezi river cascade down 100 metres into a gash in the earth, have drawn millions of holidaymakers to Zimbabwe and Zambia for their stunning views.
FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug
(Reuters) - The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, Remicade, according to the regulator's website.
Alexion Pharma rejects Elliott's push for 'proactive sale'
(Reuters) - Alexion Pharmaceuticals Inc said on Friday its board of directors had unanimously rejected hedge fund Elliott Management's push for a "proactive sale" process of the entire company because it would not be in the best interest of shareholders.
BRIEF-U.S. Records 8 Cases Of Measles In Nov 2019 - CDC
Dec 6 (Reuters) -
- More Health News Headlines